CEBPA and Hepatic fibrosis: In humans, CEBPA mRNA was decreased in MASH livers and negatively correlated with fibrosis markers, accompanied by decreased hepatic CEBPA protein levels (Figure 1, A–G), while hepatic inflammation- and fibrosis-related mRNAs were increased in MASH, indicating, as expected, that liver fibrosis is associated with MASH in humans (Supplemental Figure 1D).